Related Experiment Videos
Methadone maintenance treatment and the nonstress test
1Department of Obstetrics and Gynecology, Thomas Jefferson University Hospital, Philadelphia, Pa, USA.
Summary
Long-term in utero methadone exposure may impact fetal well-being, as indicated by nonstress tests (NSTs). This study found a lower reactivity rate in fetuses exposed to methadone compared to the general population.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Health
- Pharmacology
Background:
- Methadone is commonly used for opioid use disorder during pregnancy.
- Prenatal exposure to methadone can have various effects on fetal development.
- Nonstress tests (NSTs) are a standard method for assessing fetal well-being.
Purpose of the Study:
- To investigate the impact of long-term in utero methadone exposure on fetal performance.
- To compare nonstress test (NST) reactivity in fetuses exposed to methadone versus the general population.
Main Methods:
- Retrospective review of 28 pregnant women in an outpatient methadone maintenance program.
- Analysis of 106 nonstress tests (NSTs) conducted during the third trimester.
- Comparison of observed NST reactivity rates with published literature.
Main Results:
- The median daily methadone dosage was 60 mg.
- Reactivity was observed in 79% of NSTs from the methadone-exposed group.
- This reactivity rate was significantly lower than the reported 86% in the general population (p < 0.05).
Conclusions:
- Long-term in utero methadone exposure is associated with altered fetal performance on nonstress tests (NSTs).
- Reduced NST reactivity suggests potential effects on fetal well-being.
- Further research is warranted to understand the clinical implications of these findings.